Over 90 percent of people with Huntington’s disease develop chorea. Learn about FDA-approved VMAT2 inhibitors, off-label ...

University of Arizona researchers have revealed new insights into the neurobiological cause of the involuntary, uncontrollable movement disorders that develop in patients with Parkinson’s disease (PD) ...

University of Arizona researchers have revealed new insights into one of the most common complications faced by Parkinson's disease patients: uncontrollable movements that develop after years of ...

After five to ten years on levodopa, the gold-standard drug for Parkinson’s disease, up to 80 percent of patients develop a ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. In patients with ...

An intermediary thalamic relay station (incoming neurons in red, outgoing neurons in green). (Kuno et al., Cell Rep., 2026) A ...

Tardive dyskinesia (TD) is an involuntary movement disorder caused by long-term dopamine-blocking medications. Prolonged use may create chemical imbalances in brain areas controlling movement.

Tardive dyskinesia is a medication-induced movement disorder that causes uncontrollable muscle movements in the face, neck, and limbs. Symptoms may continue even after stopping the medication. Tardive ...